Literature DB >> 24614145

Retinal cell death and current strategies in retinal neuroprotection.

Nicholas D Chinskey1, Cagri G Besirli, David N Zacks.   

Abstract

PURPOSE OF REVIEW: Retinal cell death is the main cause of vision loss in many blinding conditions. Research on the basics of how and why retinal cells die in different diseases provides insights into the development of treatment strategies to prevent or reverse this loss. This review summarizes the literature published on this topic in the last year. RECENT
FINDINGS: Apoptosis is generally considered the main pathway by which retinal cells die in response to a range of noxious stimuli. However, inhibiting apoptosis does not completely prevent retinal cell death, as many enter programmed necrosis or necroptosis. Many novel ways of inhibiting apoptosis and necrosis, including blockage of the Fas receptor, neuroprotective peptides and antioxidants, continue to be investigated. Also, additional pathways including autophagy and inflammation are being examined on how they contribute to the loss of retinal cells in different disease models.
SUMMARY: With more knowledge of how retinal cells die, further advances are being made in prolonging the cell survival. However, even as basic science discoveries remain promising, clinical utility of neuroprotection is still quite limited at this time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614145     DOI: 10.1097/ICU.0000000000000043

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  30 in total

1.  Chapter 6 - Restoring Vision to the Blind: Neuroprotection.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

2.  Inhibiting autophagy reduces retinal degeneration caused by protein misfolding.

Authors:  Jingyu Yao; Yaoyan Qiu; Eric Frontera; Lin Jia; Naheed W Khan; Daniel J Klionsky; Thomas A Ferguson; Debra A Thompson; David N Zacks
Journal:  Autophagy       Date:  2018-07-13       Impact factor: 16.016

Review 3.  Gene therapy approaches for the treatment of retinal disorders.

Authors:  Lolita Petit; Claudio Punzo
Journal:  Discov Med       Date:  2016-10       Impact factor: 2.970

Review 4.  Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Authors:  Hannah J Yu; Charles C Wykoff
Journal:  BioDrugs       Date:  2021-04-24       Impact factor: 5.807

5.  Hypoxia-Inducible Factor-1α in Rods Is Neuroprotective Following Retinal Detachment.

Authors:  Bing X Ross; Lin Jia; Dejuan Kong; Tiantian Wang; Jingyu Yao; Heather M Hager; Steven F Abcouwer; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

6.  Absence of ephrin-A2/A3 increases retinal regenerative potential for Müller cells in Rhodopsin knockout mice.

Authors:  Rui-Lin Zhu; Yuan Fang; Hong-Hua Yu; Dong F Chen; Liu Yang; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

7.  PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa.

Authors:  Ethan Zhang; Joseph Ryu; Sarah R Levi; Jin Kyun Oh; Chun Wei Hsu; Xuan Cui; Ting-Ting Lee; Nan-Kai Wang; Jose Ronaldo Lima de Carvalho; Stephen H Tsang
Journal:  Mamm Genome       Date:  2020-04-27       Impact factor: 3.224

8.  NF-κB regulates caspase-4 expression and sensitizes neuroblastoma cells to Fas-induced apoptosis.

Authors:  Hai-Jie Yang; Mian Wang; Lei Wang; Bin-Feng Cheng; Xiao-Yu Lin; Zhi-Wei Feng
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

9.  Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis.

Authors:  Hui Shi; Jennifer A E Williams; Li Guo; Dimitrios Stampoulis; M Francesca Cordeiro; Stephen E Moss
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

10.  Regulatory networks in retinal ischemia-reperfusion injury.

Authors:  Kalina Andreeva; Maha M Soliman; Nigel G F Cooper
Journal:  BMC Genet       Date:  2015-04-24       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.